Tvardi Therapeutics, Inc.(TVRD US)
$1.37-0.042.84%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | ||
|---|---|---|---|---|---|---|---|---|
| Net Income | -20.5 | -17.3 | -70.9 | -18.2 | ||||
| Depreciation & Amortization | 0.1 | 0.1 | 0.2 | 0.1 | ||||
| Stock Based Compensation | 0.2 | 0.3 | - | 1.4 | ||||
| Change in Working Capital | 2.7 | -4.0 | -15.1 | 0.5 | ||||
| Other Non-Cash Items | -0.3 | -0.1 | 24.9 | -7.3 | ||||
| Net Cash from Operating Activities | -17.9 | -21.0 | -60.9 | -23.5 | ||||
| -Investments in Property, Plant & Equipment | -0.1 | -2.4 | -1.0 | - | ||||
| -Acquisitions Net | - | - | - | - | ||||
| -Purchases of Investments | -44.0 | -113.6 | -32.2 | -31.5 | ||||
| Sales/Maturities of Investments | 22.0 | 22.5 | 82.0 | 21.4 | ||||
| Other Investing Activities | - | 116.0 | - | - | ||||
| Net Cash from Investing Activities | -22.0 | 22.5 | 48.7 | -10.1 | ||||
| Net Debt Issuance | - | 36.5 | -3.6 | - | ||||
| Net Stock Issuance | 0.0 | 0.0 | - | 0.5 | ||||
| -Net Dividends Paid | - | - | - | - | ||||
| Other Financing Activities | - | -36.5 | - | 22.2 | ||||
| Net Cash from Financing Activities | 0.0 | 0.0 | -3.6 | 22.7 | ||||
| Effect of Forex Changes | - | - | 1.5 | - | ||||
| Net Change in Cash | -39.9 | 1.4 | -14.3 | -10.9 | ||||
| Cash at End of Period | 21.5 | 22.9 | 37.9 | 20.7 | ||||
| Operating Cash Flow | -17.9 | -21.0 | -60.9 | -23.5 | ||||
| -Capital Expenditure | -0.1 | -2.4 | -1.0 | - | ||||
| Free Cash Flow | -17.9 | -21.0 | -62.0 | -23.5 | ||||
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | ||
|---|---|---|---|---|---|---|---|---|
| Net Income | -20.5 | -17.3 | -70.9 | -18.2 | ||||
| Depreciation & Amortization | 0.1 | 0.1 | 0.2 | 0.1 | ||||
| Stock Based Compensation | 0.2 | 0.3 | - | 1.4 | ||||
| Change in Working Capital | 2.7 | -4.0 | -15.1 | 0.5 | ||||
| Other Non-Cash Items | -0.3 | -0.1 | 24.9 | -7.3 | ||||
| Net Cash from Operating Activities | -17.9 | -21.0 | -60.9 | -23.5 | ||||
| -Investments in Property, Plant & Equipment | -0.1 | -2.4 | -1.0 | - | ||||
| -Acquisitions Net | - | - | - | - | ||||
| -Purchases of Investments | -44.0 | -113.6 | -32.2 | -31.5 | ||||
| Sales/Maturities of Investments | 22.0 | 22.5 | 82.0 | 21.4 | ||||
| Other Investing Activities | - | 116.0 | - | - | ||||
| Net Cash from Investing Activities | -22.0 | 22.5 | 48.7 | -10.1 | ||||
| Net Debt Issuance | - | 36.5 | -3.6 | - | ||||
| Net Stock Issuance | 0.0 | 0.0 | - | 0.5 | ||||
| -Net Dividends Paid | - | - | - | - | ||||
| Other Financing Activities | - | -36.5 | - | 22.2 | ||||
| Net Cash from Financing Activities | 0.0 | 0.0 | -3.6 | 22.7 | ||||
| Effect of Forex Changes | - | - | 1.5 | - | ||||
| Net Change in Cash | -39.9 | 1.4 | -14.3 | -10.9 | ||||
| Cash at End of Period | 21.5 | 22.9 | 37.9 | 20.7 | ||||
| Operating Cash Flow | -17.9 | -21.0 | -60.9 | -23.5 | ||||
| -Capital Expenditure | -0.1 | -2.4 | -1.0 | - | ||||
| Free Cash Flow | -17.9 | -21.0 | -62.0 | -23.5 | ||||